PLENVU®, Powder for Oral Solution PEG 3350.

Powder for Oral Solution
PEG 3350, Sodium Ascorbate, Sodium Sulfate, Ascorbic Acid, Sodium Chloride, and Potassium Chloride

Welcome to the PLENVU® website.

To help us tailor the content and information specifically to you, please confirm your identity below.

I am a Healthcare
Professional

Find out more

I am taking PLENVU® as a
patient preparing for
colonoscopy

Find out more

PLENVU® is different to other bowel preparations you may have taken before. Please follow the instructions given to you by your healthcare professional carefully and also read the Patient Information Leaflet inside the carton.

I am a member of the public interested in learning more
about colonoscopy

Find out more

Adverse events should be reported to your regulatory agency. Adverse events should also be reported to your local
distributor or Norgine Limited, Norgine House, Moorhall Road, Harefield, Uxbridge, Middlesex, UB9 6NS, United Kingdom.
Email: globalmedinfo@norgine.com

Site

Other Sites

Small print

Registered number 30127007. Copyright Norgine 2018.

All product names mentioned in this website are trademarks owned by or licensed to the Norgine group of companies, unless otherwise noted.

Norgine B.V., Antonio Vivaldistraat 150, 1083 HP Amsterdam. The Netherlands.

PLENVU, MOVIPREP, NORGINE and the sail logo are registered trademarks of the Norgine group of companies.
ENDOCUFF VISION is a registered trademark of Arc Medical Design Limited.

Images of people are for illustrative purposes only. Any persons depicted are models and do not use or personally endorse PLENVU®.

GL/PLV/0817/0029. Date of preparation: January 2018.